AWP
ELV icon

Accretive Wealth Partners’s Elevance Health ELV Stock Holding History

Accretive Wealth Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-440
Closed -$238K – 133
2024
Q2 		$238K Sell
440
-4
-0.9% -$2.11K 0.1% 125
2024
Q1 		$234K Hold
444
– – 0.1% 127
2023
Q4 		$209K Buy
+444
New +$205K 0.1% 126
2023
Q2 		– Sell
-450
Closed -$207K – 116
2023
Q1 		$207K Buy
450
+15
+3% +$7.14K 0.13% 111
2022
Q4 		$223K Sell
435
-153
-26% -$77.7K 0.15% 105
2022
Q3 		$267K Sell
588
-31
-5% -$14.8K 0.2% 96
2022
Q2 		$299K Sell
619
-14
-2% -$6.93K 0.22% 97
2022
Q1 		$311K Hold
633
– – 0.2% 97
2021
Q4 		$293K Buy
633
+2
+0.3% +$841 0.19% 97
2021
Q3 		$235K Sell
631
-13
-2% -$4.94K 0.17% 102
2021
Q2 		$246K Sell
644
-11
-2% -$4.2K 0.18% 101
2021
Q1 		$235K Buy
655
+30
+5% +$9.65K 0.21% 93
2020
Q4 		$201K Buy
+625
New +$192K 0.2% 94

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Accretive Wealth Partners's ELV Position: Q3 2024 in Review

Accretive Wealth Partners sold out of Elevance Health (ELV) in Q3 2024, closing a stake of 440 shares — an estimated $238K sold.

Accretive Wealth Partners first reported a position in ELV in Q4 2020 and held it in 13 quarters. The position peaked at $311K in Q1 2022. 1,693 funds tracked by Wall St. Rank hold ELV as of Q3 2024.

  • Accretive Wealth Partners reported no remaining Elevance Health position as of Q3 2024 after selling out during the quarter.
  • Accretive Wealth Partners sold 440 Elevance Health shares in Q3 2024, an estimated $238K.
  • Accretive Wealth Partners first reported a position in Elevance Health in Q4 2020 and held it in 13 quarters.
  • Accretive Wealth Partners's Elevance Health position peaked at $311K in Q1 2022.
  • 1,693 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.

Based on Accretive Wealth Partners's 13F filing for Q3 2024, filed 12 Nov 2024.